FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

714187005: Product containing trastuzumab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3712236014 Product containing trastuzumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3712237017 Trastuzumab-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5471361000241113 produit contenant du trastuzumab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

12 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing trastuzumab in parenteral dose form (medicinal product form) Is a Product containing trastuzumab (medicinal product) true Inferred relationship Some
Product containing trastuzumab in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form (product) true Inferred relationship Some
Product containing trastuzumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Trastuzumab (substance) true Inferred relationship Some 1
Product containing trastuzumab in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Product containing trastuzumab in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab 150 mg powder for solution for injection vial Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Some
Trastuzumab 440 mg powder for solution for injection vial Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Some
Trastuzumab only product in parenteral dose form Is a True Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form) Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Some
Trastuzumab emtansine-containing product in parenteral dose form Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing pertuzumab and trastuzumab in parenteral dose form (medicinal product form) Is a True Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start